Results 71 to 80 of about 2,021,559 (378)

Surgical myocardial revascularization of patients with ischemic cardiomyopathy and severe left ventricular disfunction

open access: yesClinics, 2010
OBJECTIVE: To determine long-term survival, identify preoperative factors predictive of a favorable outcome, and assess functional improvement after coronary artery bypass grafting in patients with advanced left ventricular dysfunction.
André L. Hovnanian   +6 more
doaj   +1 more source

Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction

open access: yesDiagnostics, 2023
Heart failure with reduced ejection fraction (HFrEF) is considered a major health care problem with frequent decompensations, high hospitalization and mortality rates.
Syuzanna Shahnazaryan   +2 more
doaj   +1 more source

Two step ejection of massive stars and the issue of their formation in isolation

open access: yes, 2010
In this paper we investigate the combined effect of massive binary ejection from star clusters and a second acceleration of a massive star during a subsequent supernova explosion. We call this the "two-step-ejection" scenario.
Blaauw   +27 more
core   +1 more source

Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial [PDF]

open access: yes, 2016
Background—The prevalence of pre–diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known.
Cardoso, José Silva   +17 more
core   +1 more source

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction

open access: yesCirculation Research, 2021
Supplemental Digital Content is available in the text. Rationale: Heart failure with preserved ejection fraction (HFpEF) is a mortal clinical syndrome without effective therapies.
Dan Tong   +13 more
semanticscholar   +1 more source

Novel pathways of heart failure with preserved ejection fraction [PDF]

open access: yes, 2016
INTRODUCTION: Diastolic heart failure (HF) i.e., HF with preserved ejection fraction (HFpEF) accounts for ~50% of all clinical HF presentations; but unlike systolic HF i.e., HF with reduced ejection fraction (HFrEF), there are no evidenced based ...
Li, Shanpeng
core   +2 more sources

Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

open access: yesEuropean Journal of Heart Failure, 2021
The lack of effective therapies for patients with heart failure with preserved ejection fraction (HFpEF) is often ascribed to the heterogeneity of patients with HFpEF.
Rebecca J. Woolley   +15 more
semanticscholar   +1 more source

Influence of ejection fraction on cause‐specific mortality in heart failure with preserved ejection fraction [PDF]

open access: yesEuropean Journal of Heart Failure, 2017
Peer Reviewed ; https://deepblue.lib.umich.edu/bitstream/2027.42/143697/1/ejhf1040.pdf ; https://deepblue.lib.umich.edu/bitstream/2027.42/143697/2/ejhf1040_am ...
Bajaj, Navkaranbir S.   +13 more
openaire   +4 more sources

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Risk factors for heart failure with preserved ejection fraction (HFpEF) include hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota independently contributes to each one of these risk factors, potentially ...
A. Beale   +11 more
semanticscholar   +1 more source

Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial

open access: yesCardiovascular Diabetology
Background Clinical trials have established the prognostic benefits of sodium‒glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and heart failure (HF) with preserved ejection fraction (HFpEF), although the ...
Artem Ovchinnikov   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy